Tag Archives: EXEL

Top 5 Heal Care Stocks To Watch Right Now

There’s a veritable hurricane of events–not to mention an actual hurricane–that should be rocking the market–but stocks barely moved today as investors wait for the U.S. payrolls data tomorrow.

Getty Images

The S&P 500 ticked up 0.1% to 2,160.77 today, while the Dow Jones Industrial Average dipped 12.53 points, or 0.1%, to 18,268.50. The Nasdaq Composite declined 0.2% to 5,306.85.

Rhino Trading’s Michael Block considers the market’s lack of action:

…global markets continue to stumble around in a tight band, unable to break out or just plain break, it seems. Yesterday we saw a nice rally driven by bullish oil inventories and talk of an OPEC meeting before the meeting next week. That was undone by chatter that the German government was seeking discreet talks with the U.S. authorities on Deutsche Bank (DB). Thats code for they need to fix that before everyone gets sick, and fixing things means short term pain.

Top 5 Heal Care Stocks To Watch Right Now: OSI Systems, Inc.(OSIS)

Advisors’ Opinion:

  • [By Shane Hupp]

    Here are some of the headlines that may have impacted Accern’s rankings:

    Get OSI Systems alerts:

    OSI Systems (OSIS) Rating Increased to Buy at Zacks Investment Research (americanbankingnews.com) OSI Systems (OSIS) Downgraded by BidaskClub (americanbankingnews.com) OSI Systems (OSIS) Downgraded by Zacks Investment Research to Hold (americanbankingnews.com) $274.42 Million in Sales Expected for OSI Systems, Inc. (OSIS) This Quarter (americanbankingnews.com) Zacks: Analysts Expect OSI Systems, Inc. (OSIS) Will Post Earnings of $0.94 Per Share (americanbankingnews.com)

    OSIS has been the subject of several research reports. Sidoti initiated coverage on OSI Systems in a research note on Wednesday, February 21st. They issued a “buy” rating for the company. Zacks Investment Research raised OSI Systems from a “hold” rating to a “buy” rating and set a $69.00 price objective for the company in a research note on Wednesday, April 4th. ValuEngine lowered OSI Systems from a “hold” rating to a “sell” rating in a research note on Wednesday, May 2nd. Jefferies Group lowered OSI Systems from a “buy” rating to a “hold” rating and dropped their price objective for the company from $79.00 to $70.00 in a research note on Friday, February 2nd. They noted that the move was a valuation call. Finally, BidaskClub lowered OSI Systems from a “sell” rating to a “strong sell” rating in a research note on Saturday, January 20th. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating and four have given a buy rating to the stock. The company presently has an average rating of “Hold” and an average price target of $86.20.

  • [By Logan Wallace]

    Millennium Management LLC lessened its stake in shares of OSI Systems, Inc. (NASDAQ:OSIS) by 40.1% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 255,483 shares of the technology company’s stock after selling 170,680 shares during the quarter. Millennium Management LLC owned about 1.41% of OSI Systems worth $16,675,000 at the end of the most recent reporting period.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on OSI Systems (OSIS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 5 Heal Care Stocks To Watch Right Now: Iridium Communications Inc(IRDM)

Advisors’ Opinion:

  • [By Max Byerly]

    Iridium Communications (NASDAQ: IRDM) and Inseego (NASDAQ:INSG) are both small-cap computer and technology companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, earnings, analyst recommendations, institutional ownership, dividends, risk and profitability.

  • [By Logan Wallace]

    Gargoyle Investment Advisor L.L.C. cut its holdings in Iridium Communications Inc (NASDAQ:IRDM) by 16.2% during the first quarter, according to its most recent Form 13F filing with the SEC. The firm owned 23,251 shares of the technology company’s stock after selling 4,500 shares during the period. Gargoyle Investment Advisor L.L.C.’s holdings in Iridium Communications were worth $262,000 as of its most recent filing with the SEC.

  • [By Joseph Griffin]

    Iridium Communications (NASDAQ: IRDM) and AAC TECHNOLOGIE/ADR (OTCMKTS:AACAY) are both computer and technology companies, but which is the better investment? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, risk, dividends, profitability, institutional ownership and valuation.

  • [By Max Byerly]

    Prudential Financial Inc. decreased its holdings in shares of Iridium Communications Inc (NASDAQ:IRDM) by 6.0% in the 1st quarter, according to its most recent Form 13F filing with the SEC. The firm owned 1,187,699 shares of the technology company’s stock after selling 75,910 shares during the period. Prudential Financial Inc. owned approximately 1.08% of Iridium Communications worth $13,361,000 as of its most recent SEC filing.

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Iridium Communications (IRDM)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 5 Heal Care Stocks To Watch Right Now: U.S. Physical Therapy, Inc.(USPH)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on U.S. Physical Therapy (USPH)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 5 Heal Care Stocks To Watch Right Now: Exelixis, Inc.(EXEL)

Advisors’ Opinion:

  • [By Shane Hupp]

    Old Mutual Global Investors UK Ltd. raised its holdings in Exelixis, Inc. (NASDAQ:EXEL) by 26.6% during the first quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 3,562,369 shares of the biotechnology company’s stock after purchasing an additional 747,398 shares during the quarter. Old Mutual Global Investors UK Ltd. owned 1.20% of Exelixis worth $78,906,000 as of its most recent SEC filing.

  • [By ]

    Another biotech worth considering is Exelixis Inc. (NASDAQ: EXEL).

    The company recently received FDA approval of a new cancer treatment that according to a recent NASDAQ industry report should further boost demand and send share values higher.

  • [By Stephan Byrd]

    Wedbush Securities Inc. purchased a new position in shares of Exelixis (NASDAQ:EXEL) in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 14,215 shares of the biotechnology company’s stock, valued at approximately $315,000.

Top 5 Heal Care Stocks To Watch Right Now: Coeur d’Alene Mines Corporation(CDE)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Coeur Mining Inc (NYSE:CDE) – Equities researchers at Cormark lifted their Q2 2018 earnings estimates for Coeur Mining in a note issued to investors on Tuesday, July 10th. Cormark analyst R. Gray now anticipates that the basic materials company will earn ($0.02) per share for the quarter, up from their previous estimate of ($0.05). Cormark also issued estimates for Coeur Mining’s Q3 2018 earnings at $0.02 EPS, Q4 2018 earnings at $0.07 EPS, FY2018 earnings at $0.07 EPS, Q1 2019 earnings at $0.15 EPS, Q2 2019 earnings at $0.15 EPS, Q3 2019 earnings at $0.15 EPS, Q4 2019 earnings at $0.15 EPS and FY2019 earnings at $0.60 EPS.

  • [By Reuben Gregg Brewer]

    There’s no way to sugarcoat it:2017 was not a particularly good year for shareholders of silver and gold miner Coeur Mining, Inc. (NYSE:CDE). When it comes to investing, though, you need to balance the past with the future, and this miner’s efforts in 2017 look like they will set up a much better long-term future. Here’s why precious metals investors should be taking a closer look at Coeur Mining, but probably shouldn’t rush to pull the trigger.

  • [By Shane Hupp]

    Franco Nevada (NYSE: FNV) and Coeur Mining (NYSE:CDE) are both basic materials companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, analyst recommendations, valuation, profitability, dividends, risk and institutional ownership.

Top 10 Gold Stocks For 2019

Gerardo Del Real, a leading metals and mining expert, recently launched the Resource Stock Digest. In December, he had rare opportunity to interview the legendary James Dines.

Gerardo Del Real: This is Gerardo Del Real for Resource Stock Digest. I have a real treat for you today. Joining me today is the legendary Mr. James Dines. Mr. Dines is the editor of The Dines Letter. He’s also authored several books including Goldbug!, Technical Analysis, Secrets of High States, and Mass Psychology.

Mr. Dines has a legendary record in the investment community. His contrarian approach to investment analysis has led Mr. Dines to accurately forecast trends for many decades, from the unexpected gold boom of 1974, to the internet revolution of 1996, Mr. Dines has consistently gone against the grain and delivered gains that have been passed down for generations.

Top 10 Gold Stocks For 2019: Exelixis, Inc.(EXEL)

Advisors’ Opinion:

  • [By Shane Hupp]

    Old Mutual Global Investors UK Ltd. raised its holdings in Exelixis, Inc. (NASDAQ:EXEL) by 26.6% during the first quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 3,562,369 shares of the biotechnology company’s stock after purchasing an additional 747,398 shares during the quarter. Old Mutual Global Investors UK Ltd. owned 1.20% of Exelixis worth $78,906,000 as of its most recent SEC filing.

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    MDC Partners Inc. (NASDAQ: MDCA) fell 23.4 percent to $5.25 in pre-market trading after a first-quarter earnings miss.
    Hudson Technologies Inc. (NASDAQ: HDSN) shares fell 15.1 percent to $3.48 in pre-market trading after the company reported downbeat Q1 earnings.
    Nuance Communications, Inc. (NASDAQ: NUAN) fell 14 percent to $13.15 in pre-market trading after the company posted downbeat Q2 earnings and lowered FY18 organic growth guidance.
    Myomo, Inc. (NYSE: MYO) fell 13.2 percent to $3.10 in pre-market trading after reporting downbeat quarterly results.
    Rowan Companies plc (NYSE: RDC) shares fell 10.7 percent to $14.13 in pre-market trading after climbing 8.50 percent on Wednesday.
    BT Group plc (NYSE: BT) fell 9 percent to $14.80 in pre-market trading after the company reported Q4 results and announced plans to cut 13,000 jobs over the next three years.
    Exelixis, Inc. (NASDAQ: EXEL) fell 8.3 percent to $19.90 in pre-market trading after the company disclosed that IMblaze370 Phase 3 pivotal trial of atezolizumab and cobimetinib in patients with heavily pretreated locally advanced or metastatic colorectal cancer did not meet primary endpoint.
    Infinera Corporation (NASDAQ: INFN) fell 8.2 percent to $10.80 in pre-market trading after reporting Q1 results.
    Synaptics, Incorporated (NASDAQ: SYNA) shares fell 7.4 percent to $43.00 in pre-market trading. Synaptics reported better-than-expected earnings for its third quarter, while sales missed estimates.
    Randgold Resources Limited (NASDAQ: GOLD) shares fell 7.4 percent to $76.23 in pre-market trading after reporting Q1 earnings.
    Integra LifeSciences Holdings Corporation (NASDAQ: IART) shares fell 7 percent to $59.36 in pre-market trading. Integra LifeSciences priced its 5.25 million share public offering of common stock at $58.50 per share.
    Array BioPharma Inc. (NASDAQ: ARRY) shares fell 6.9 percent to $12.75 in pre-m

  • [By Max Byerly]

    BidaskClub upgraded shares of Exelixis (NASDAQ:EXEL) from a strong sell rating to a sell rating in a report released on Friday.

    EXEL has been the subject of a number of other research reports. Cann restated a buy rating and set a $40.00 price objective on shares of Exelixis in a research note on Wednesday, May 30th. ValuEngine lowered Exelixis from a sell rating to a strong sell rating in a research note on Friday, May 11th. William Blair reaffirmed a buy rating on shares of Exelixis in a report on Wednesday, April 11th. Oppenheimer raised Exelixis from a market perform rating to an outperform rating and set a $40.00 target price on the stock in a report on Tuesday, February 27th. Finally, Stifel Nicolaus reduced their target price on Exelixis from $30.00 to $29.00 and set a hold rating on the stock in a report on Thursday, May 3rd. Two investment analysts have rated the stock with a sell rating, four have given a hold rating and nine have issued a buy rating to the company’s stock. The company has a consensus rating of Hold and an average price target of $32.80.

Top 10 Gold Stocks For 2019: Rocky Mountain Chocolate Factory Inc.(RMCF)

Advisors’ Opinion:

  • [By Max Byerly]

    Rocky Mountain Chocolate Factory (NASDAQ: RMCF) and Tootsie Roll Industries (NYSE:TR) are both small-cap retail/wholesale companies, but which is the better investment? We will compare the two companies based on the strength of their risk, valuation, dividends, analyst recommendations, earnings, profitability and institutional ownership.

  • [By Ethan Ryder]

    Rocky Mountain Chocolate Factory (NASDAQ: RMCF) and Tootsie Roll Industries (NYSE:TR) are both small-cap retail/wholesale companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, risk, earnings, institutional ownership, profitability, dividends and analyst recommendations.

Top 10 Gold Stocks For 2019: EPAM Systems, Inc.(EPAM)

Advisors’ Opinion:

  • [By Logan Wallace]

    Schwab Charles Investment Management Inc. increased its position in EPAM Systems (NYSE:EPAM) by 4.1% in the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 360,326 shares of the information technology services provider’s stock after purchasing an additional 14,329 shares during the quarter. Schwab Charles Investment Management Inc.’s holdings in EPAM Systems were worth $41,265,000 as of its most recent filing with the Securities & Exchange Commission.

  • [By Dan Caplinger]

    Constant advances in technology require companies of all sizes to make efforts to keep up and take maximum advantage of new capabilities before competitors do. That puts companies like EPAM Systems (NYSE:EPAM) in a great position, because the resulting demand for IT services is constant and growing. EPAM did a good job of fulfilling its potential for strong growth in 2017, and the IT services specialist has high hopes that 2018 will bring even more gains.

  • [By Ethan Ryder]

    These are some of the media headlines that may have impacted Accern Sentiment’s scoring:

    Get EPAM Systems alerts:

    33 Top US Companies Short-Listed in 10 categories for USA-Europe Shared Services Awards, June 20th, New York (benzinga.com) Alexion SmartPanel Developed in Partnership With EPAM Wins Judges’ Prize in the 2018 Bio-IT World Best Practices … (globenewswire.com) Alexion SmartPanel Developed in Partnership With EPAM Wins Judges Prize in the 2018 Bio-IT World Best Practices Awards (finance.yahoo.com) Financial Review: NTT DATA Corp/ADR (NTDTY) and EPAM Systems (EPAM) (americanbankingnews.com) What is RPA? A revolution in business process automation (computerworld.com.au)

    A number of equities analysts recently commented on the company. Zacks Investment Research raised EPAM Systems from a “hold” rating to a “buy” rating and set a $132.00 price objective on the stock in a research note on Monday, April 23rd. Needham & Company LLC lifted their price objective on EPAM Systems to $130.00 and gave the stock a “buy” rating in a research note on Tuesday, February 20th. They noted that the move was a valuation call. Stifel Nicolaus reaffirmed a “buy” rating and issued a $135.00 price objective (up from $105.00) on shares of EPAM Systems in a research note on Friday, February 16th. ValuEngine raised EPAM Systems from a “hold” rating to a “buy” rating in a research note on Monday, April 2nd. Finally, KeyCorp reaffirmed an “overweight” rating and issued a $132.00 price objective (up from $123.00) on shares of EPAM Systems in a research note on Tuesday, February 20th. Three research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company. The stock currently has a consensus rating of “Buy” and a consensus target price of $125.25.

Top 10 Gold Stocks For 2019: 21Vianet Group, Inc.(VNET)

Advisors’ Opinion:

  • [By Stephan Byrd]

    21Vianet Group (NASDAQ:VNET) was upgraded by analysts at BidaskClub from a “sell” rating to a “hold” rating in a report issued on Tuesday.

  • [By Joseph Griffin]

    21Vianet Group (NASDAQ: VNET) and 58.com (NYSE:WUBA) are both computer and technology companies, but which is the superior stock? We will contrast the two companies based on the strength of their dividends, risk, earnings, profitability, valuation, analyst recommendations and institutional ownership.

  • [By Lisa Levin] Gainers
    Blink Charging Co. (NASDAQ: BLNK) shares climbed 31.68 percent to close at $7.19 on Wednesday. Blink Charging reported Q1 net income of $2.2 million, versus a year-ago net loss of $3.1 million.
    Eleven Biotherapeutics, Inc. (NASDAQ: EBIO) shares gained 24.15 percent to close at $3.29. Eleven Biotherapeutics posted a Q1 loss of $0.11 per share.
    21Vianet Group, Inc. (NASDAQ: VNET) shares surged 24 percent to close at $6.82.
    Check-Cap Ltd. (NASDAQ: CHEK) gained 20.25 percent to close at $4.87.
    HUYA Inc. (NYSE: HUYA) shares surged 18.42 percent to close at $22.50
    Abaxis, Inc. (NASDAQ: ABAX) rose 16.15 percent to close at $83.34. Zoetis Inc. (NYSE: ZTS) announced plans to acquire Abaxis for $83 per share in cash.
    Pain Therapeutics, Inc. (NASDAQ: PTIE) shares jumped 16.07 percent to close at $10.62.
    Bilibili Inc. (NASDAQ: BILI) rose 16.04 percent to close at $14.11.
    Gemphire Therapeutics Inc. (NASDAQ: GEMP) gained 14.88 percent to close at $6.33.
    Phoenix New Media Limited (NYSE: FENG) rose 13.96 percent to close at $5.55.
    Daqo New Energy Corp. (NYSE: DQ) jumped 13.88 percent to close at $67.27 on Wednesday.
    Sea Limited (NYSE: SE) jumped 12.59 percent to close at $11.98 after reporting Q1 results.
    Viking Therapeutics, Inc. (NASDAQ: VKTX) rose 12.01 percent to close at $5.13.
    Ascena Retail Group, Inc. (NASDAQ: ASNA) gained 11.93 percent to close at $3.19.
    Boot Barn Holdings, Inc. (NYSE: BOOT) climbed 11.66 percent to close at $24.52 on Wednesday after the company reported upbeat results for its fourth quarter and issued strong first-quarter earnings guidance.
    Macy's, Inc. (NYSE: M) rose 10.83 percent to close at $33.17 after the company reported stronger-than-expected results for its first quarter and lifted guidance.
    ChemoCentryx, Inc. (NASDAQ: CCXI) gained 9.36 percent to close at $12.50. Canaccord Genuity initiated coverage on ChemoCentryx with a Buy rating.
    Biolinerx Ltd/S ADR (NASDAQ: BLRX)
  • [By Lisa Levin] Gainers
    SenesTech, Inc. (NASDAQ: SNES) shares jumped 113.5 percent to $0.6737 after the California Department of Pesticide Regulation proposed to register the company's ContraPest for sale and use in California.
    AgEagle Aerial Systems, Inc. (NASDAQ: UAVS) shares rose 35.34 percent to close at $3.32.
    Art's-Way Manufacturing Co., Inc. (NASDAQ: ARTW) shares gained 30.36 percent to $3.65.
    Xtant Medical Holdings, Inc. (NYSE: XTNT) shares jumped 25.6 percent to $7.4701 after the company disclosed that it has received the FDA clearance for InTice™-C Porous Titanium Cervical Interbody System.
    VAALCO Energy, Inc. (NYSE: EGY) shares surged 20 percent to $2.495.
    TransGlobe Energy Corporation (NASDAQ: TGA) surged 17.04 percent to $2.61.
    Boxlight Corporation (NASDAQ: BOXL) gained 15 percent to $8.32 after the company announced an exclusive partnership with Multi Touch Interactives to strengthen the development of next generation interactive educational activities.
    Arcimoto, Inc. (NASDAQ: FUV) gained 15 percent to $3.39.
    MB Financial, Inc. (NASDAQ: MBFI) rose 13.7 percent to $49.64. Fifth Third Bancorp (NASDAQ: FITB) agreed to acquire MB Financial for $54.70 per share in cash and stock.
    FRONTEO, Inc. (NASDAQ: FTEO) shares rose 11.8 percent to $20.956.
    TransEnterix, Inc. (NYSE: TRXC) shares jumped 11.1 percent to $3.38.
    21Vianet Group, Inc. (NASDAQ: VNET) rose 10.6 percent to $7.41.
    NII Holdings, Inc. (NASDAQ: NIHD) shares gained 9 percent to $2.32.
    Kelly Services, Inc. (NASDAQ: KELYA) rose 7.6 percent to $24.19. Northcoast Research upgraded Kelly Services from Neutral to Buy.
    LaSalle Hotel Properties (NYSE: LHO) shares climbed 5.6 percent to $33.70. Blackstone Group LP (NYSE: BX) will buy LaSalle Hotel Properties in a $4.8 billion deal, Bloomberg reported.
    Alteryx, Inc. (NYSE: AYX) gained 5.5 percent to $32.56. KeyBanc upgraded Alteryx from Sector Weight to Overweight.
    Energizer Holdings, Inc. (NYSE:
  • [By Lisa Levin] Gainers
    SenesTech, Inc. (NASDAQ: SNES) shares surged 296.07 percent to close at $1.25 on Monday after the California Department of Pesticide Regulation proposed to register the company's ContraPest for sale and use in California.
    AgEagle Aerial Systems, Inc. (NASDAQ: UAVS) shares gained 19.59 percent to close at $2.93.
    TransGlobe Energy Corporation (NASDAQ: TGA) rose 18.39 percent to close at $2.64 on Monday.
    Sears Hometown and Outlet Stores, Inc. (NASDAQ: SHOS) shares gained 15.91 percent to close at $2.55.
    VAALCO Energy, Inc. (NYSE: EGY) shares jumped 14.9 percent to close at $2.39.
    Resonant Inc. (NASDAQ: RESN) climbed 13.96 percent to close at $4.49.
    Chesapeake Energy Corporation (NYSE: CHK) shares rose 13.55 percent to close at $4.61 on Monday.
    Lilis Energy, Inc. (NYSE: LLEX) surged 13.09 percent to close at $5.01.
    MB Financial, Inc. (NASDAQ: MBFI) gained 12.9 percent to close at $49.28. Fifth Third Bancorp (NASDAQ: FITB) agreed to acquire MB Financial for $54.70 per share in cash and stock.
    TransEnterix, Inc. (NYSE: TRXC) shares rose 12.83 percent to close at $3.43.
    World Wrestling Entertainment, Inc. (NYSE: WWE) jumped 12.52 percent to close at $57.86 on Reports that it has reached a deal with Fox for Its 'Smackdown Live' program.
    Eastman Kodak Company (NASDAQ: KODK) rose 12.38 percent to close at $5.90.
    NuCana plc (NASDAQ: NCNA) climbed 11.94 percent to close at $26.44. NuCana appointed Dr. Cyrille Leperlier to its Board as an independent non-executive Director.
    Aqua Metals, Inc. (NASDAQ: AQMS) rose 11.83 percent to close at $3.97 on Monday.
    Huami Corporation (NYSE: HMI) shares jumped 11.27 percent to close at $10.17 following Q1 results.
    21Vianet Group, Inc. (NASDAQ: VNET) gained 9.55 percent to close at $7.34.
    Boxlight Corporation (NASDAQ: BOXL) rose 8.56 percent to close at $7.86 after the company announced an exclusive partnership with Multi Touch Interactives to strengthen the de

Top 10 Gold Stocks For 2019: Sanderson Farms Inc.(SAFM)

Advisors’ Opinion:

  • [By Logan Wallace]

    ValuEngine cut shares of Sanderson Farms (NASDAQ:SAFM) from a strong-buy rating to a buy rating in a research report released on Wednesday morning.

  • [By Ethan Ryder]

    Shares of Sanderson Farms, Inc. (NASDAQ:SAFM) have been assigned an average rating of “Hold” from the thirteen brokerages that are currently covering the company, MarketBeat Ratings reports. Four investment analysts have rated the stock with a sell recommendation, seven have assigned a hold recommendation and one has assigned a buy recommendation to the company. The average 12 month target price among brokers that have issued ratings on the stock in the last year is $111.75.

  • [By Lisa Levin]

    Tuesday morning, the consumer staples shares surged 0.17 percent. Meanwhile, top gainers in the sector included CV Sciences, Inc. (OTC: CVSI), up 6 percent, and Sanderson Farms, Inc. (NASDAQ: SAFM) up 5 percent.

  • [By Stephan Byrd]

    Federated Investors Inc. PA cut its position in Sanderson Farms, Inc. (NASDAQ:SAFM) by 71.5% in the first quarter, HoldingsChannel reports. The firm owned 20,286 shares of the company’s stock after selling 51,010 shares during the quarter. Federated Investors Inc. PA’s holdings in Sanderson Farms were worth $2,415,000 at the end of the most recent reporting period.

  • [By Stephan Byrd]

    Shares of Sanderson Farms, Inc. (NASDAQ:SAFM) have been given a consensus recommendation of “Hold” by the thirteen research firms that are covering the stock, Marketbeat.com reports. Three research analysts have rated the stock with a sell recommendation, eight have given a hold recommendation and one has assigned a buy recommendation to the company. The average 12 month price target among analysts that have covered the stock in the last year is $111.75.

Top 10 Gold Stocks For 2019: Sun Life Financial Inc.(SLF)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Sentry Investments Corp. grew its holdings in Sun Life Financial (NYSE:SLF) (TSE:SLF) by 2.3% in the first quarter, HoldingsChannel reports. The institutional investor owned 531,100 shares of the financial services provider’s stock after buying an additional 11,900 shares during the quarter. Sentry Investments Corp.’s holdings in Sun Life Financial were worth $28,101,000 at the end of the most recent reporting period.

  • [By Lisa Levin]

     

    Companies Reporting After The Bell
    Marriott International, Inc. (NASDAQ: MAR) is projected to post quarterly earnings at $1.22 per share on revenue of $5.72 billion.
    Electronic Arts Inc. (NASDAQ: EA) is estimated to post quarterly earnings at $1.04 per share on revenue of $5.68 billion.
    The Walt Disney Company (NYSE: DIS) is projected to post quarterly earnings at $1.68 per share on revenue of $14.05 billion.
    Papa John's International, Inc. (NASDAQ: PZZA) is expected to post quarterly earnings at $0.62 per share on revenue of $441.73 million.
    Jazz Pharmaceuticals plc (NASDAQ: JAZZ) is projected to post quarterly earnings at $2.77 per share on revenue of $434.87 million.
    Sun Life Financial Inc. (NYSE: SLF) is estimated to post quarterly earnings at $0.89 per share on revenue of $6.38 billion.
    LATAM Airlines Group S.A. (NYSE: LTM) is expected to post quarterly earnings at $0.16 per share on revenue of $2.70 billion.
    Liberty Global plc (NASDAQ: LBTYA) is projected to post quarterly earnings at $0.02 per share on revenue of $4.05 billion.
    TripAdvisor, Inc. (NASDAQ: TRIP) is expected to post quarterly earnings at $0.16 per share on revenue of $362.11 million.
    The Wendy's Company (NASDAQ: WEN) is projected to post quarterly earnings at $0.1 per share on revenue of $379.98 million.
    A-Mark Precious Metals, Inc. (NASDAQ: AMRK) is expected to post quarterly earnings at $0.06 per share on revenue of $1.69 billion.
    Monster Beverage Corporation (NASDAQ: MNST) is estimated to post quarterly earnings at $0.4 per share on revenue of $849.38 million.
    Convergys Corporation (NYSE: CVG) is expected to post quarterly earnings at $0.4 per share on revenue of $670.10 million.
    ScanSource, Inc. (NASDAQ: SCSC) is projected to post quarterly earnings at $0.7 per share on revenue of $875.91 million.
    KAR Auction Services, Inc. (NYSE: KAR) is expected to post quarterly earnings at $0.76 per share on revenue of $923.13

  • [By Max Byerly]

    Sun Life Financial (NYSE: SLF) and Scor (OTCMKTS:SCRYY) are both finance companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, risk, profitability, earnings and valuation.

Top 10 Gold Stocks For 2019: Citizens Financial Group, Inc.(CFG)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Citizens Financial Group Inc (NYSE:CFG) insider Randall J. Black sold 792 shares of Citizens Financial Group stock in a transaction on Tuesday, June 5th. The shares were sold at an average price of $41.49, for a total value of $32,860.08. Following the completion of the transaction, the insider now owns 34,258 shares in the company, valued at $1,421,364.42. The sale was disclosed in a document filed with the SEC, which is available at the SEC website.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Citizens Financial Group (CFG)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shanthi Rexaline]

    Citizens Financial Group Inc (NYSE: CFG) shares were down Tuesday, dragged by macro concerns following the rise in Italian sovereign debt yields and a 14-basis point decline in the 10-year U.S. treasury yield.

  • [By Max Byerly]

    M&T Bank Corp lowered its stake in Citizens Financial Group (NYSE:CFG) by 38.5% during the 1st quarter, HoldingsChannel reports. The firm owned 52,349 shares of the bank’s stock after selling 32,830 shares during the quarter. M&T Bank Corp’s holdings in Citizens Financial Group were worth $2,198,000 at the end of the most recent reporting period.

Top 10 Gold Stocks For 2019: AxoGen, Inc.(AXGN)

Advisors’ Opinion:

  • [By Shane Hupp]

    AxoGen, Inc (NASDAQ:AXGN) – Analysts at William Blair raised their Q2 2018 earnings estimates for AxoGen in a research report issued on Monday, May 14th. William Blair analyst K. Krum now expects that the medical equipment provider will post earnings per share of ($0.04) for the quarter, up from their prior forecast of ($0.05). William Blair currently has a “Outperform” rating on the stock. William Blair also issued estimates for AxoGen’s Q4 2018 earnings at ($0.03) EPS and FY2018 earnings at ($0.25) EPS.

  • [By Lee Jackson]

    Jefferies started coverage on this top biotech/medtech firm last year with a Buy rating. AxoGen Inc. (NASDAQ: AXGN) offers surgical solutions for peripheral nerve injuries. It provides products and education to improve surgical treatment algorithms for peripheral nerve injuries. Its portfolio of products includes Avance Nerve Graft, AxoGuard Nerve Connector, AxoGuard Nerve Protector and Avive Soft Tissue Membrane.

  • [By Joseph Griffin]

    These are some of the media stories that may have impacted Accern’s analysis:

    Get AxoGen alerts:

    Analysts Anticipate AxoGen, Inc (AXGN) Will Announce Earnings of -$0.06 Per Share (americanbankingnews.com) The SVP Sales of AxoGen (NASDAQ: AXGN) is Selling Shares (analystratings.com) BRIEF-Axogen Inc Says On May 15, Board Elected CEO Zaderej To Succeed Grooms As Chairman (reuters.com) AxoGen, Inc (AXGN) SVP Shawn F. Mccarrey Sells 10,000 Shares (americanbankingnews.com) Global Nerve Repair Biomateria Market Report 2018-2023 -Axogen, Integra, Synovis, Collagen Matrix, Polyganics … (talkdailynews.com)

    AxoGen opened at $43.95 on Monday, Marketbeat reports. AxoGen has a fifty-two week low of $13.95 and a fifty-two week high of $46.00. The company has a debt-to-equity ratio of 0.82, a quick ratio of 2.81 and a current ratio of 3.32. The company has a market cap of $1.52 billion, a P/E ratio of -141.77 and a beta of -0.04.

  • [By Lee Jackson]

    This is another biotech/medical technology that Jefferies started coverage on with a Buy rating late last year. AxoGen Inc. (NASDAQ: AXGN) offers surgical solutions for peripheral nerve injuries. The Company provides products and education to improve surgical treatment algorithms for peripheral nerve injuries. Its portfolio of products includes Avance Nerve Graft, AxoGuard Nerve Connector, AxoGuard Nerve Protector and Avive Soft Tissue Membrane.

Top 10 Gold Stocks For 2019: Landstar System, Inc.(LSTR)

Advisors’ Opinion:

  • [By Asit Sharma]

    Jacksonville, Florida-based third-party logistics (3PL) providerLandstar System, Inc. (NASDAQ:LSTR) enjoyed record revenue in the first quarter of 2018. The handsome $1.05 billion top line was accompanied by record quarterlygross profit of $155.5 million. Investors have applauded the performance: Though volatile, Landstar’s stock has gained nearly 9% year to date, and over a 12-month period, the LSTR symbol has returned nearly 29%. As we look ahead to second-quarter results, which will be reported next month, can the Landstar maintain the vigorous earnings momentum that has supported its stock price ascent?

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Landstar System (LSTR)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    Landstar System (NASDAQ: LSTR) and YRC Worldwide (NASDAQ:YRCW) are both transportation companies, but which is the better business? We will compare the two companies based on the strength of their dividends, valuation, earnings, analyst recommendations, profitability, institutional ownership and risk.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Landstar System (LSTR)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Gold Stocks For 2019: Sonic Corp.(SONC)

Advisors’ Opinion:

  • [By Max Byerly]

    SG Americas Securities LLC raised its stake in Sonic Drive-In (NASDAQ:SONC) by 70.9% in the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 6,285 shares of the restaurant operator’s stock after buying an additional 2,608 shares during the quarter. SG Americas Securities LLC’s holdings in Sonic Drive-In were worth $159,000 at the end of the most recent quarter.

  • [By Jeremy Bowman]

    Shares ofSonic Corporation(NASDAQ:SONC) were flying higher today after the fast-food, drive-up chain reported preliminary third-quarter results and said it would increase share buybacks. The stock rose throughout the day and closed up 16.4%.

  • [By Stephan Byrd]

    Darden Restaurants (NYSE: DRI) and Sonic Drive-In (NASDAQ:SONC) are both retail/wholesale companies, but which is the superior investment? We will contrast the two businesses based on the strength of their dividends, risk, analyst recommendations, earnings, profitability, institutional ownership and valuation.

  • [By Leo Sun]

    Shares of Sonic (NASDAQ:SONC) tumbled 5% onJune 27, after the fast-food chain posted mixed third-quarter numbers. Its revenue fell 5% year over year to $118.3 million, which missed expectations by $0.35 million and marked its eighth straight quarter of declining sales.

  • [By Logan Wallace]

    Sonic Drive-In (NASDAQ:SONC) was downgraded by equities research analysts at ValuEngine from a “hold” rating to a “sell” rating in a research note issued to investors on Wednesday.

  • [By Logan Wallace]

    ValuEngine upgraded shares of Sonic Drive-In (NASDAQ:SONC) from a sell rating to a hold rating in a report issued on Thursday morning.

    Several other equities research analysts have also recently commented on the company. Barclays cut their price target on Sonic Drive-In from $28.00 to $25.00 and set an underweight rating for the company in a report on Wednesday, March 28th. Zacks Investment Research cut Sonic Drive-In from a buy rating to a hold rating in a report on Thursday, March 15th. BidaskClub raised Sonic Drive-In from a sell rating to a hold rating in a report on Tuesday, March 20th. Cowen cut their price target on Sonic Drive-In from $29.00 to $28.00 and set a market perform rating for the company in a report on Wednesday, March 28th. Finally, Morgan Stanley cut their price target on Sonic Drive-In from $29.00 to $28.00 and set an equal weight rating for the company in a report on Monday, March 26th. One research analyst has rated the stock with a sell rating, eleven have assigned a hold rating and five have issued a buy rating to the company’s stock. The stock presently has an average rating of Hold and a consensus target price of $28.67.

Crispr Therapeutics: Assessing The Recent Capital Financing

The reason why the growth stocks do so much better is that they seem to show gains in value in the hundreds of percent each decade. In contrast, it is an unusual bargain that is as much as 50 percent undervalued. The cumulative effect of this simple arithmetic should be obvious. – Philip Fisher (the Father of Growth Investing)

On Jan 05, 2018, the share price of Crispr Therapeutics (NASDAQ:CRSP), a bioscience focusing on gene-editing and CAR-T to treat serious conditions such as cancers and genetic diseases, continued its rally. The stock added another $2.90 (over 12% profits) to value at $26.81 for the said trading session. Since we recommended the company on Nov. 27, 2017 (just over a month) to subscribers of Integrated BioSci Investing, the stock added another $7.26 (or 37% in capital appreciation). This robust run-up is interesting because, on Jan. 04, 2018, the company announced that the 5M additional common shares issued on Jan 03 will be priced at $22.75.

Figure 1: Crispr stock chart. (Source: Stockcharts).

At Integrated BioSci Investing (IBI), we have much success in finding robust performers. For instance, Nektar Therapeutics (NASDAQ:NKTR) appreciated over 200% for subscribers. Exelixis Inc procured over 50% profits. In this report, we’ll assess the ramifications of the recent financing and to reaffirm the investment thesis on Crispr.

Fundamentals Analysis

Back in 2017, there were several stellar medical breakthroughs that have ramifications that can be as far reaching as the introduction of chemotherapy more than a decade prior. Accordingly, the US FDA approved Yescarta (a CAR-T indicated for the treatment of non-Hodgkin lymphoma). The said molecule was innovated by Kite Pharma (NASDAQ:KITE) – a firm acquired by Gilead Sciences(NASDAQ:GILD). Moreover, the agency also approved the first gene therapy, Luxturna (voretigene neparvovec-rzyl), a molecule innovated by Sparks Therapeutics (NASDAQ:ONCE). It is a one-time treatment for patients afflicted with biallelic RPE65 mutation-associated retinal dystrophy.

In the midst of the aforesaid favorable regulatory environment for medical breakthroughs, the Switzerland-based company, Crispr Therapeutics is also brewing a revolutionary method of treating cancers and rare genetic diseases. As follows, CRISPR/Cas9 is a form of gene-editing currently being investigated in various conditions (as shown in the enriched pipeline in figure 2). The company also has a gene-editing enhanced form of CAR-T in development for various cancers. Of most interest is the lead molecule, CTX-001 (also a gene-editing therapeutic) that can be potentially used for the management of serious blood disorders: beta-thalassemia and sickle cell disease (SCD).

Figure 2: Therapeutic pipeline. (Source: Crispr).

Final Remarks

As alluded, Crispr recently issued another 5M common shares at the price of $22.75. The company also granted the underwriters a 30-day option to purchase up to 750K of its common shares. The expected gross proceeds from this offering are roughly $113.75M (excluding any exercise of the underwriters option to purchase additional shares). Moreover, the offering is expected to close on Jan. 09. The company employed Goldman Sachs (NYSE:GS), Piper Jaffray (NYSE:PJC), Barclays Capital (NYSE:BCS), and Guggenheim Securities as joint book-running managers for the said offerings. We strongly believe that the aforesaid capital financing is both strategic and prudent, as substantial capital (in the ballpark of over a billion dollars) is needed to fund a molecule from bench research to commercialization. With the share price appreciating, it is wise that the firm issued new shares to strengthen its capital for further pipeline innovation. There is an in-depth Integrated BioSci version of this research, which is available in advanced to subscribers of Integrated BioSci Investing.

Authors Notes: Were honored that you took the time out of your busy day to read our market intelligence. Founded by Dr. Hung Tran, MD, MS, CNPR, (in collaborations with Dr. Tran BioSci analyst, Ngoc Vu, and other PhDs), Integrated BioSci Investing (IBI) marketplace research is delivering stellar returns since inceptions. To name a few, Nektar Therapeutics (NASDAQ:NKTR) procured more than 210% profits; Spectrum Pharmaceuticals (NASDAQ:SPPI) delivered over 180% gains; Kite Pharma netted 82%. Exelixis Inc (NASDAQ:EXEL) earned greater than 50% capital appreciation. Our secret sauce is extreme due diligence coupled with expert data analysis. The service features a once-weekly exclusive in-depth Integrated BioSci Alpha-Intelligence article (in the form of research, reports, or interviews), daily individual stocks consulting, and model portfolios.

Notably, well increase our price soon. SUBSCRIBE to our marketplace research now to lock in the legacy price and save money in the future. To receive real-time alerts on our articles as well as blogs, be sure to check out our profile page and CLICK the orange FOLLOW button . Asides the exclusivities, this article is the truncated version of the research we published in advance to IBI subscribers. Further, you can read up on Dr. Trans background by following this link.

Disclosure: I/we have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours.

I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

About this article:ExpandAuthor payment: Seeking Alpha pays for exclusive articles. Payment calculations are based on a combination of coverage area, popularity and quality.Tagged: Investing Ideas, Long Ideas, Healthcare, Biotechnology, SwitzerlandWant to share your opinion on this article? Add a comment.Disagree with this article? Submit your own.To report a factual error in this article, click here

Top 10 Low Price Stocks To Watch For 2018

The title of this article may generate strong responses from some, who will reply: “never!” And indeed, if a value trap is defined as a stock that is not a value, then clearly a value trap is never a value. (There aren’t many rich dialetheists on Wall Street.) But let’s take a more nuanced view of a value trap and follow Investopedia.com in defining a value trap, which I quote at some length:

A value trap is a stock that appears to be cheap because the stock has been trading at low multiples of earnings, cash flow or book value for an extended time period. Value traps attract investors who are looking for a bargain because these stocks are inexpensive. The trap springs when investors buy into the company at low prices and the stock never improves. Trading that occurs at low multiples of earnings, cash flow or book value for long periods of time might indicate that the company or the entire sector is in trouble, and that stock prices may not move higher.

When is such a stock, that may not move higher and may never improve, worth buying? This article aims to provide an outline of an answer to that question. Along the way I’ll attempt to note places where I am simplifying the treatment or ignoring potentially important considerations.

Top 10 Low Price Stocks To Watch For 2018: SPDR Wells Fargo Preferred Stock ETF (PSK)

Advisors’ Opinion:

  • [By Todd Shriber, ETF Professor]

    DWFI holds five other SSgA fixed income ETFs, including the SPDR Wells Fargo Preferred Stock ETF (NYSE: PSK). PSK is DWFI's largest holding at a weight of 25.2 percent. DWFI's second-largest holding is an allocation of almost 25 percent to the SPDR Nuveen Barclays Municipal Bond ETF (NYSE: TFI).

Top 10 Low Price Stocks To Watch For 2018: MicroStrategy Incorporated(MSTR)

Advisors’ Opinion:

  • [By Jim Robertson]

    Small cap Alarm.com Holdings would bethe leading platform for the intelligently connected property. Millions of people depend on Alarm.com Holdings technology to monitor and control their property from anywhere. Centered on security and remote monitoring, the Companys platform addresses a wide range of market needs and enables application-based control for a growing variety of Internet of Things (IoT) devices.Its security, video monitoring, intelligent automation and energy management solutions are available througha network of thousands of professional service providers in North America and around the globe. The Company went public in June 2015 as a spinoff from MicroStrategy Incorporated (NASDAQ: MSTR) with shares selling for $14 during the IPO.

  • [By Chris Neiger]

    MicroStrategy (NASDAQ:MSTR) reported its first-quarter results on April 27, and the company saw its total revenue tick up by 1.3% year over year. Just as with the company’s fourth-quarter results, MicroStrategy’s management said foreign-currency headwinds continued to have a negative impact on the company’s overall sales.

Top 10 Low Price Stocks To Watch For 2018: Blackrock Global(BOE)

Advisors’ Opinion:

  • [By Robert Rapier]

    Whiting Petroleum (WLL) is one of Continental’s biggest competitors in the Bakken. Whiting is the second-largest oil producer in North Dakota, averaging 82,500 barrels of oil equivalent (BOE) of production in 2012, across more than 700,000 acres of leased land.

Top 10 Low Price Stocks To Watch For 2018: Adaptimmune Therapeutics plc(ADAP)

Advisors’ Opinion:

  • [By Jon C. Ogg]

    Adaptimmune Therapeutics PLC (NASDAQ: ADAP) was started with a Market Perform at Wells Fargo.

    Aqua America Inc. (NYSE: WTR) was raised to Overweight from Equal Weight and the price target was raised to $36 from $33 (versus a $31.19 close) at Barclays.

Top 10 Low Price Stocks To Watch For 2018: Great Canadian Gaming Corporation (GCGMF)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    Clairvest Group previously initiated an investment in a partnership that involved Great Canadian Gaming Corporation (OTCPK:GCGMF) and Brookfield Business Partners LP to operate two casinos in Southern Ontario. With this announcement, we not only get the upside of a 45% ownership of “Ontario Gaming West GLA Limited Partnership,” which includes four major operations, but also 2,500 slot machines, 60 table games, racing track and $450 million in gross gaming revenue. Clairvest has a history in the gambling industry and Great Canadian Gaming Corporation is a proven operator with a terrific track record.

  • [By SEEKINGALPHA.COM]

    SA: You recently published a thesis on Great Canadian Gaming (OTCPK:GCGMF), a Canadian company do you see the Canadian (or another) market as having greater opportunity to uncover hidden value than the U.S.?

Top 10 Low Price Stocks To Watch For 2018: Asbury Automotive Group Inc(ABG)

Advisors’ Opinion:

  • [By Inyoung Hwang]

    Fresnillo Plc (FRES) and Polymetal International Plc sank at least 7 percent to lead declines in the Stoxx 600 after the precious-metals producers were not included in the NYSE Arca Gold Miners Index. Fresnillo tumbled 13 percent to 1,045 pence. Polymetal plunged 7.1 percent to 659.5 pence. African Barrick Gold Plc (ABG) also fell, losing 12 percent to 143.9 pence.

Top 10 Low Price Stocks To Watch For 2018: National Steel Corporation(SID)

Advisors’ Opinion:

  • [By Lisa Levin]

    Basic materials shares climbed by 1.52 percent in trading on Friday. Meanwhile, top gainers in the sector included Companhia Siderurgica Nacional (ADR) (NYSE: SID), and Core Molding Technologies, Inc. (NYSE: CMT).

Top 10 Low Price Stocks To Watch For 2018: Westell Technologies, Inc.(WSTL)

Advisors’ Opinion:

  • [By Jim Robertson]

    Today, our Under the Radar Moversnewsletter suggested small cap high-performance wireless infrastructure solutions stock Westell Technologies (NASDAQ: WSTL) as a buy for our short-term portfolio:

Top 10 Low Price Stocks To Watch For 2018: SuperValu Inc.(SVU)

Advisors’ Opinion:

  • [By Demitrios Kalogeropoulos]

    As for individual stocks, RetailMeNot (NASDAQ:SALE) and SUPERVALU (NYSE:SVU) attracted heavy investor interest following merger and acquisition news.

  • [By Peter Graham]

    Small cap grocery store stock SUPERVALU Inc (NYSE: SVU) reported Q2 2018 earnings before the market opened this morning which topped Wall Street expectations. Q2 net sales were $3.80 billion versus $2.81 billionas Wholesale net salesrose 58% to$2.74 billion and Retail net salesfell 1.1% to$1.02 billion.The net loss from continuing operationswas $25 million (which included a $27 million after-tax asset impairment charge and $16 million of after-tax merger and integration costs) versus net income of $31 million. The CEO commented:

  • [By Steve Symington]

    The stock market was flat on Thursday ahead of a key House vote on the Republicans’ healthcare bill, which was delayed until Friday as GOP lawmakers failed to gather enough votes to proceed. TheDow Jones Industrial Averagelost just 5 points, or 0.02%, while other broader market indexes saw similar small declines.But several individual stocks delivered outsized positive returns today, including FireEye (NASDAQ:FEYE), Penn National Gaming (NASDAQ:PENN), and SUPERVALU Inc. (NYSE:SVU). Read on to see what caused these unusual positive moves.

Top 10 Low Price Stocks To Watch For 2018: Exelixis, Inc.(EXEL)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Wednesday, healthcare shares fell by 0.91 percent. Meanwhile, top losers in the sector included Alere Inc (NYSE: ALR), down 8 percent, and Exelixis, Inc. (NASDAQ: EXEL), down 10 percent.

  • [By Chris Lange]

    Exelixis Inc. (NASDAQ: EXEL) saw its shares make a handy gain on Wednesday after the company was tapped by the U.S. Food and Drug Administration (FDA). Specifically, the FDA has approved Cabometyx (cabozantinib) tablets for the expanded indication of patients with advanced renal cell carcinoma (RCC), which is the most common form of kidney cancer in adults.

penny stock forum

Eight U.S. senate Democrats are seeking a federal investigation of whether Trump adviser Carl Icahn violated insider trading or other lawswith his investments and advice involvingrenewable fuel credits.

In a Tuesday letterto federal financial and environmental agencies, the group questioned whether the billionaire activist investor influenced the Trump administration in ways that would drive down the price of renewable fuel credits. Such a drop would benefit CVR Energy, a company largely owned by Icahn that is heavily involved in the market for the fuel credits, the senators wrote.

“We are writing to request that your agencies investigate whether Carl Icahn violated insider trading laws, anti-market manipulation laws, or any other relevant laws based on his recent actions in the market for renewable fuel credits,” the letter stated. While acknowledging that the group did not know if Icahn had done anything wrote, they wrote that “the publicly available evidence is troubling.”

penny stock forum: Texas Instruments Incorporated(TXN)

Advisors’ Opinion:

  • [By Lee Jackson]

    This old-school chip tech company was out of favor but has come back solid.Texas Instruments Inc. (NASDAQ: TXN) is a global semiconductor design and manufacturing company that develops analog integrated circuits and embedded processors.

  • [By Jim Cramer]

    Net operating cash flow has slightly increased to $1,409.00 million or 1.87% when compared to the same quarter last year. In addition, TEXAS INSTRUMENTS INC has also modestly surpassed the industry average cash flow growth rate of -5.51%.

     

  • [By Jon C. Ogg]

    Texas Instruments Inc. (NASDAQ: TXN) closed out 2016 at $72.97, and Merrill Lynch has a price objective of $82.00. If you consider the 2.7% dividend yield, Merrill Lynch is calling for Texas Instruments to generate a return of 15%. What investors might want to consider is that the consensus analyst target price is $74.89, very close to the current price, but Merrill Lynch’s price objective is exactly $10 less than the most aggressive price target on Wall Street. Texas Instruments has a 52-week range of $46.73 to $75.25. RBC was also positive here on Texas Instruments and other large caps.

  • [By Keith Speights]

    That’s a pretty good definition of leadership, but it’s not an easy one to accomplish. However, the CEOs of Celgene (NASDAQ:CELG), Cognizant Technology Solutions (NASDAQ:CTSH), General Electric (NYSE:GE), MasterCard (NYSE:MA), and Texas Instruments (NASDAQ:TXN) have been able to achieve this translation very well.

  • [By WWW.THESTREET.COM]

    Xilinx makes programmable logic chips that are used in a multitude of applications, from autos and defense to the data center. Cramer said with all of the takeover activity in the semiconductor space, he could see Xilinx becoming a target for the likes of Texas Instruments (TXN) or Micron Technologies (MU) , which may be looking to diversify away from cell phone chips.

penny stock forum: Exelixis, Inc.(EXEL)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Wednesday, healthcare shares fell by 0.91 percent. Meanwhile, top losers in the sector included Alere Inc (NYSE: ALR), down 8 percent, and Exelixis, Inc. (NASDAQ: EXEL), down 10 percent.

  • [By Chris Lange]

    Exelixis Inc. (NASDAQ: EXEL) saw its shares make a handy gain on Wednesday after the company was tapped by the U.S. Food and Drug Administration (FDA). Specifically, the FDA has approved Cabometyx (cabozantinib) tablets for the expanded indication of patients with advanced renal cell carcinoma (RCC), which is the most common form of kidney cancer in adults.

penny stock forum: Oak Valley Bancorp (CA)(OVLY)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Tuesday, financial shares fell 0.32 percent. Meanwhile, top losers in the sector included Oak Valley Bancorp (NASDAQ: OVLY), down 7 percent, and AmTrust Financial Services Inc (NASDAQ: AFSI) down 5 percent.

penny stock forum: Exelon Corporation(EXC)

Advisors’ Opinion:

  • [By Lisa Levin]

    Utilities shares climbed by 0.64 percent in trading on Friday. Meanwhile, top gainers in the sector included Exelon Corporation (NYSE: EXC), and FirstEnergy Corp. (NYSE: FE).

  • [By Monica Gerson]

    Analysts are expecting Exelon Corporation (NYSE: EXC) to have earned $0.68 per share on revenue of $7.52 billion in the latest quarter. Exelon shares rose 0.34 percent to close at $35.38 on Thursday.

  • [By Horizon Investments]

    For the past year, Exelon Corp. (EXC) has had a roller coaster ride, with the stock having plummeted 15% since September 2012 – the company had announced a dividend cut of 41%, which led to a drop in the share price. Separately, the recent weak PJM auction prices did not bode well for the company. However, I believe the worst is priced in the stock price, and the company’s management is committed to improving its financial flexibility and cost structure in order to strengthen its financial performance. Also, the company is planning to incur capital expenditure (CAPEX) in the upcoming years, which will result in rate base growth for Exelon.

  • [By Monica Gerson]

    Exelon Corporation (NYSE: EXC) is expected to report its quarterly earnings at $0.68 per share on revenue of $7.52 billion.

    CST Brands Inc (NYSE: CST) is projected to report its quarterly earnings at $0.22 per share on revenue of $2.30 billion.

  • [By Casey Wilson]

    That brings us to General Electric Co. (NYSE: GE). The 125-year-old American mainstay signed a deal with Exelon Corp. (NYSE: EXC) last fall for the energy utility to use its own predictive analytics software, fittingly dubbed “Predix.”